Susan Engerman
Papers
1
Total Citations
20
H-Index
1
About
Susan Engerman is a clinical researcher whose work focuses on the early detection and prediction of acute kidney injury (AKI), particularly in the context of urological surgery. Her most cited study, "Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy," demonstrated the feasibility of using novel urinary biomarkers—such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1)—to identify AKI hours before traditional serum creatinine changes. This work, which has garnered 20 citations, addresses a critical gap in perioperative nephrology: the need for timely intervention to prevent irreversible renal damage. Engerman’s contributions are especially relevant to patients undergoing partial nephrectomy, a procedure that inherently risks renal function. By validating non-invasive, real-time biomarkers, her research paves the way for personalized risk stratification and proactive management of AKI. Her findings have implications for improving surgical outcomes and reducing long-term kidney complications, making her a key figure in the intersection of urology and nephrology.
Research Focus
Key Achievements
Top Papers
- 1